Press Releases

Varian Reports Results for Fourth Quarter and Full Fiscal Year 2018

Fourth Quarter 2018 Summary – Oncology gross orders grew 13% in dollars, or 14% in constant currency – 84 Halcyon orders in the quarter – Total company revenues of $802 million grew 11%, or...

Varian and GenesisCare to Form Strategic Partnership for Cancer Care Research and Increased Access to Care

Varian (NYSE: VAR) and GenesisCare, a leading provider of cancer care treatment, today announced the signing of a memorandum of understanding (MoU) to form a strategic partnership for cancer care...

Varian Ranked First in Probability of Repurchase and Overall Manufacturer, System, and Service Performance in 2018 Survey of Radiation Oncology Professionals

Varian (NYSE: VAR) today announced it has been ranked first in seven categories, including probability of repurchase, overall manufacturer performance, overall system performance and overall...

Varian Outlines Strategy for AI-Driven Multimodality Adaptive Radiotherapy Suite

During its Users Meeting at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting, Varian (NYSE: VAR) shared details of its development work on an artificial intelligence...

Varian Unveils New Bravos Afterloader System for Brachytherapy Treatments

Varian (NYSE: VAR) today announced the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy treatments. Based on over five years of in-clinic research, Bravos is an integrated...

Varian Forms FlashForward Consortium to Study Ultra-high Dose Rate Cancer Treatments with Protons

To expand the encouraging preclinical and translational research already conducted by Varian (NYSE: VAR) and two of its clinical partners, Maryland Proton Treatment Center and Cincinnati...

Varian Introduces New ProBeam 360° Proton Therapy System

Varian (NYSE: VAR) today announced its new single-room proton therapy system, ProBeam® 360°. With a 30 percent smaller footprint than the previous system, ProBeam 360° offers uncompromised...

Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition

Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported...

Varian Signs Educational Partnerships with Reliance Group in India

Varian (NYSE: VAR) today announced it has signed an educational partnership with one of India's leading hospital groups to provide greater access to training in advanced radiotherapy and...

Varian Appoints New Division Presidents

Varian (NYSE: VAR), today announced it has appointed Kolleen T. Kennedy, formerly president of Varian Oncology Systems (VOS) to a new role as president of Proton Solutions, the division formerly...